The body gets used to the changes: reducing discomfort at the beginning of Tirzetta® therapy

The body gets used to the changes: reducing discomfort at the beginning of Tirzette therapy®

The body gets used to the changes: reducing discomfort at the beginning of Tirzetta® therapy
In this article

Starting treatment with any drugs is often associated with the adaptation of the body, especially if it is a drug that affects the metabolism. Tirzetta®is the first Russian drug based on tirzepatide, which triggers a cascade of changes: it helps to reduce body weight, reduce appetite, and stabilize sugar levels. And for all these changes, the body needs time to rebuild itself.

The first weeks are a period of habituation. Nausea, constipation, or, conversely, loosening of the stool are possible. These are not side effects in the usual sense, but a natural reaction to metabolic changes. They pass as the body finds a new balance.

Why this happens and how you can support yourself during this period without stress and unnecessary anxiety — we will tell you below.


The physiological explanation of adaptation

The mechanism of action of tirzepatide is based on the activation of two incretin receptors at once — GLP-1 and GIPl. So far, this is the first and only substance with such a dual effect. 
Both receptors are involved in the regulation of glucose metabolism, appetite, and energy balance. Simultaneous action on these pathways gives a multicomponent therapeutic effect.

What happens in the body:
  • Appetite decreases due to the effect on the saturation centers in the brain.
  • Gastric emptying slows down — this helps to maintain a feeling of fullness for longer and reduces the rate of glucose absorption.
  • Glycemic control improves: insulin production increases and glucagon secretion decreases, but only with normal or elevated blood sugar levels. This is especially important in cases of insulin resistance.
Thanks to this comprehensive approach, tirzepatide helps to reduce weight, including visceral fat, while maintaining muscle mass. At the same time, glucose control is improving in patients with type 2 diabetes.

Therefore, slight changes in digestive function may occur at the beginning of therapy. Such reactions are due to the fact that the drug slows down intestinal motility — this is part of its action. According to a systematic review published in the journal Medicine in 2023.1, gastrointestinal reactions to tirzepatide, such as nausea, constipation or diarrhea, are most often temporary and decrease as the body adapts to the drug.

№4_TWIGA_Промомед_Тирзетта_Сайт_Организм привыкает к изменениям_ снижаем дискомфорт в начале терапии Тирзетта®.jpg


Temporary nature of reactions

Physical and emotional reactions to treatment are the norm, not an indicator of the ineffectiveness of therapy. They appear in the first days or weeks after using the drug and usually subside within 2-4 weeks.

According to a large randomized trial, SURMOUNT-1 2, published in The New England Journal of Medicine, gastrointestinal symptoms were observed in 79-82% of patients, but in most cases were short-lived, mild or moderate in severity.


How to support the body during therapy

Like any therapy that affects metabolism, tirzepatide requires a period of adaptation.

In the case of Tirzetta,®changes in digestion, appetite, and energy levels are possible in the first weeks. The good news is that gentle lifestyle adjustments can significantly reduce discomfort and help your body adjust to a new routine. We'll tell you how to do this below.

Nutrition: a calm stomach means stable well—being

  • Less fatty and heavy food: it takes longer to digest and can increase nausea.
  • The formula of the plate: half — vegetables, a quarter — low—fat protein (turkey fillet without skin), a quarter - complex carbohydrates (for example, quinoa, buckwheat or whole grain bread).
  • Add more fiber: zucchini, broccoli, legumes, bran. It improves digestion and helps to avoid constipation.
  • Switching to fractional mode: 5-6 small meals a day. This approach will reduce the load on the gastrointestinal tract and help the body adapt to new metabolic conditions.

Water Balance: A simple solution that works

  • Maintain water balance: at least 1.5–2 liters of water per day. More when physically active. 
  • Exclude carbonated and sugary drinks: they can cause bloating and increase discomfort.
  • If you show signs of dehydration or fatigue after training, you can temporarily add isotonics to your diet.

Movement: regularity is more important than intensity

  • Start by walking: 20-30 minutes a day is enough to maintain metabolism and stimulate intestinal motility.
  • Add physical exercises 2-3 times a week (for example, with your own weight): they help to maintain muscle mass.
  • A simple morning workout: even 5 minutes of activity triggers blood circulation and improves overall well-being.

Sleep and regime: the foundation of recovery

  • Try to sleep at least 7-8 hours, go to bed and wake up at the same time: this supports hormonal balance and reduces evening cravings for food.
  • If dinner is late, it is better to choose a light snack: a little protein and vegetables will be enough.

Attention to well-being

  • It is useful to keep short notes: weight, sugar level (for diabetes), general condition, nutrition, stool. Such notes will help you see connections and notice changes in time. 
  • It is important for diabetic patients to regularly monitor glucose levels, especially against the background of weight loss, when dosage adjustments may be required.
Mild gastrointestinal reactions at the beginning of therapy are a temporary phenomenon that does not reduce the effectiveness of treatment. However, the persistence or progression of these symptoms requires medical advice.



The material is for reference purposes only and does not replace a doctor's advice. The diagnosis and treatment regimen are determined by the attending physician.



Information sources: 

1. Tong K., Yin S., Yu Y., Yang X., Hu G., Zhang F., Liu Z. Gastrointestinal adverse events of tirzepatide in the treatment of type 2 diabetes mellitus: A meta-analysis and trials sequential analysis // Medicine. 2023. Vol. 102, No. 43. pp. e35488. DOI: 10.1097/MD.0000000000035488.

2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–216. doi:10.1056/NEJMoa2206038.